352 related articles for article (PubMed ID: 25496842)
1. Diagnosis of incidental thyroid nodules on 18F-fluorodeoxyglucose positron emission tomography imaging: are these significant?
Sharma SD; Jacques T; Smith S; Watters G
J Laryngol Otol; 2015 Jan; 129(1):53-6. PubMed ID: 25496842
[TBL] [Abstract][Full Text] [Related]
2. Incidental Thyroid Nodules at Non-FDG PET Nuclear Medicine Imaging: Evaluation of Prevalence and Malignancy Rate.
Yerubandi V; Chin BB; Sosa JA; Hoang JK
AJR Am J Roentgenol; 2016 Feb; 206(2):420-5. PubMed ID: 26797373
[TBL] [Abstract][Full Text] [Related]
3. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
[TBL] [Abstract][Full Text] [Related]
4. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
Sebastianes FM; Cerci JJ; Zanoni PH; Soares J; Chibana LK; Tomimori EK; de Camargo RY; Izaki M; Giorgi MC; Eluf-Neto J; Meneghetti JC; Pereira MA
J Clin Endocrinol Metab; 2007 Nov; 92(11):4485-8. PubMed ID: 17684046
[TBL] [Abstract][Full Text] [Related]
5. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ
Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887
[TBL] [Abstract][Full Text] [Related]
6. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review.
Soelberg KK; Bonnema SJ; Brix TH; Hegedüs L
Thyroid; 2012 Sep; 22(9):918-25. PubMed ID: 22827552
[TBL] [Abstract][Full Text] [Related]
7. Correlation of BRAF mutation and SUV
Ozderya A; Temizkan S; Gul AE; Ozugur S; Sargin M; Aydin K
Endocrine; 2017 Jan; 55(1):215-222. PubMed ID: 27696232
[TBL] [Abstract][Full Text] [Related]
8. Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
Brindle R; Mullan D; Yap BK; Gandhi A
Eur J Surg Oncol; 2014 Nov; 40(11):1528-32. PubMed ID: 24915858
[TBL] [Abstract][Full Text] [Related]
9. Can the pathology of a thyroid nodule be determined by positron emission tomography uptake?
Boeckmann J; Bartel T; Siegel E; Bodenner D; Stack BC
Otolaryngol Head Neck Surg; 2012 Jun; 146(6):906-12. PubMed ID: 22307576
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography (PET/CT) in patients with non-thyroidal malignancy.
Wong C; Lin M; Chicco A; Benson R
Acta Radiol; 2011 Oct; 52(8):899-904. PubMed ID: 21873505
[TBL] [Abstract][Full Text] [Related]
11. Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers.
Nam SY; Roh JL; Kim JS; Lee JH; Choi SH; Kim SY
Clin Endocrinol (Oxf); 2007 Jul; 67(1):135-9. PubMed ID: 17465995
[TBL] [Abstract][Full Text] [Related]
12. Focal thyroid incidental uptake detected by ¹⁸F-fluorodeoxyglucose positron emission tomography. Meta-analysis on prevalence and malignancy risk.
Treglia G; Bertagna F; Sadeghi R; Verburg FA; Ceriani L; Giovanella L
Nuklearmedizin; 2013; 52(4):130-6. PubMed ID: 23765102
[TBL] [Abstract][Full Text] [Related]
13. Thyroid incidentalomas detected on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography: Thyroid Imaging Reporting and Data System (TIRADS) in the diagnosis and management of patients.
Yoon JH; Cho A; Lee HS; Kim EK; Moon HJ; Kwak JY
Surgery; 2015 Nov; 158(5):1314-22. PubMed ID: 25958065
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical significance in our setting of incidental uptake in the thyroid gland found on 18F-fluordeoxyglucose positron emission tomography-computed tomography (PET-CT).
Familiar C; Merino S; Valhondo R; López C; Pérez X; De Los Monteros PE; Hernández F; Pazos M; Pallarés R; Pascual AC
Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70(3):171-178. PubMed ID: 37030900
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk of cancer of thyroid incidentaloma identified by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Yang Z; Shi W; Zhu B; Hu S; Zhang Y; Wang M; Zhang J; Yao Z; Zhang Y
J Otolaryngol Head Neck Surg; 2012 Oct; 41(5):327-33. PubMed ID: 23092835
[TBL] [Abstract][Full Text] [Related]
16. Review. 18F-FDG PET in the diagnosis and follow-up of thyroid malignancy.
Al-Nahhas A; Khan S; Gogbashian A; Banti E; Rampin L; Rubello D
In Vivo; 2008; 22(1):109-14. PubMed ID: 18396792
[TBL] [Abstract][Full Text] [Related]
17. Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography.
Shie P; Cardarelli R; Sprawls K; Fulda KG; Taur A
Nucl Med Commun; 2009 Sep; 30(9):742-8. PubMed ID: 19561553
[TBL] [Abstract][Full Text] [Related]
18. Cytological evaluation by fine needle aspiration biopsy of incidental focal increased fluorodeoxyglucose uptake in thyroid on positron emission tomography scan.
Li Y; Cui M; Azar N; Nakamoto D; Michael CW
Diagn Cytopathol; 2017 Jun; 45(6):501-506. PubMed ID: 28261999
[TBL] [Abstract][Full Text] [Related]
19. Is it possible to predict malignancy in cases with focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography?
Fujii T; Yajima R; Yamaguchi S; Tsutsumi S; Asao T; Kuwano H
Am Surg; 2012 Jan; 78(1):141-3. PubMed ID: 22273333
[No Abstract] [Full Text] [Related]
20. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography.
Salvatori M; Melis L; Castaldi P; Maussier ML; Rufini V; Perotti G; Rubello D
Biomed Pharmacother; 2007 Sep; 61(8):488-93. PubMed ID: 17604940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
